1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Influenza Vaccines Market – By Vaccine Type

1.3.2        North America Influenza Vaccines Market – By Virus Type

1.3.3        North America Influenza Vaccines Market – By Technology

1.3.4        North America Influenza Vaccines Market – By Route of Administration

1.3.5        North America Influenza Vaccines Market – By Target Group

1.3.6        North America Influenza Vaccines Market – By Country

2.           North America Influenza Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Influenza Vaccines Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Influenza Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Government Support to Promote Influenza Vaccination

5.1.2        Increasing Investment by Top Market Players and Governments

5.2         Market Restraints

5.2.1        High Cost of Vaccine Development

5.3         Market Opportunities

5.3.1        Emerging Economies

5.4         Future Trends

5.4.1        Strong Pipeline Candidates for Influenza Vaccines

5.5         Impact Analysis

6.           Influenza Vaccine Market –North America Analysis

6.1         North America Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2         North America Influenza Vaccines Market Revenue Forecasts And Analysis – 2020- 2028 (US$ Mn)

6.2.1        North America: Influenza Vaccines Market, 2019–2028 (US$ Million)

7.           North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1         Overview

7.2         North America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1        North America: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

7.3         Quadrivalent Vaccines

7.3.1        Overview

7.3.2        Quadrivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Trivalent Vaccines

7.4.1        Overview

7.4.2        Trivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.           North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1         Overview

8.2         North America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1        North America: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

8.3         Influenza Virus Type A

8.3.1        Overview

8.3.2        Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Influenza Virus Type B

8.4.1        Overview

8.4.2        Influenza Virus Type B : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.           North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1         Overview

9.2         North America Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1        North America: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

9.3         Egg-based

9.3.1        Overview

9.3.2        Egg-based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Cell-based

9.4.1        Overview

9.4.2        Cell-Based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.        North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1      Overview

10.2      North America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.2.1     North America: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

10.3      Injection

10.3.1     Overview

10.3.2     Injection : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Nasal Spray

10.4.1     Overview

10.4.2     Nasal Spray: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.        North America Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1      Overview

11.2      North America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1     North America: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3      Infants

11.3.1     Overview

11.3.2     Infants : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Children

11.4.1     Overview

11.4.2     Children: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Adults

11.5.1     Overview

11.5.2     Adults : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6      Elderly People

11.6.1     Overview

11.6.2     Elderly People: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12.        North America Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1      North America Influenza Vaccines Market Revenue and Forecasts To 2028

12.1.1     Overview

12.1.2     North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

12.1.2.1       US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1       Overview

12.1.2.1.2       US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3       US: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.1.4       US: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.1.5       US: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.1.6       US: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.1.7       US: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.2       Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1       Overview

12.1.2.2.2       Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3       Canada: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.2.4       Canada: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.2.5       Canada: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.2.6       Canada: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.2.7       Canada: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.3       Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1       Overview

12.1.2.3.2       Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3       Mexico: Influenza Vaccines Market, by Vaccine Type, 2019–2028 (US$ Million)

12.1.2.3.4       Mexico: Influenza Vaccines Market, by Virus Type, 2019–2028 (US$ Million)

12.1.2.3.5       Mexico: Influenza Vaccines Market, by Technology, 2019–2028 (US$ Million)

12.1.2.3.6       Mexico: Influenza Vaccines Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.3.7       Mexico: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13.        North America Influenza Vaccine Market –Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3      Inorganic Growth Strategies

13.3.1     Overview

13.4      Organic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      Moderna, Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      SEQIRUS

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Sanofi

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline plc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Emergent BioSolutions Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Mitsubishi Chemical Group Corporation

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Serum Institute of India Pvt. Ltd

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      MYLAN N.V.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      AstraZeneca

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms 

LIST OF TABLES

Table 1.             Below are a few instances of companies and their pipeline products:

Table 2.             North America Influenza Vaccines Market– Revenue and Forecast to 2028 (USD Million)

Table 3.             North America Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             North America: Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             North America Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6.             North America Influenza Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 7.             North America Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 8.             US Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             US Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          US Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 11.          US Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 12.          US Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Canada Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Canada Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Canada Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Canada Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 18.          Mexico Influenza Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Mexico Influenza Vaccines Market, by Virus Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Mexico Influenza Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Mexico Influenza Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Mexico Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 23.          Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 24.          Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 25.          Glossary of Terms, Influenza Vaccines Market 

LIST OF FIGURES

Figure 1.           North America Influenza Vaccines Market Segmentation

Figure 2.           North America Influenza Vaccines Market Segmentation, by Country

Figure 3.           North America Influenza Vaccines Market Overview

Figure 4.           Quadrivalent Vaccines Segment Held Largest Share of Product Segment in North America Influenza Vaccines Market

Figure 5.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9.           North America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10.        Quadrivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Trivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        North America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13.        Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Influenza Virus Type B: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        North America Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16.        Egg-based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Cell-Based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        North America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19.        Injection: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Nasal Spray: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        North America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22.        Infants: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        Children: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Adults: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Elderly People: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        North America: Influenza Vaccines Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27.        North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)

Figure 28.        US: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.          Growth Strategies in the Influenza Vaccine Market, 2021-2028